FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002292011> ?p ?o ?g. }

• W2002292011 endingPage "2855" @default.
• W2002292011 startingPage "2847" @default.
• W2002292011 abstract "The risk of hip and other fractures was examined among a population-based group of older women with breast cancer. Women using aromatase inhibitors (AIs) were found to be over three times more likely to have a hip fracture over approximately 3 years’ follow-up. Other fracture risk factors were also identified. Aromatase inhibitors have been shown in randomized trials to increase total fracture risk compared with tamoxifen, but the fracture risks in the trials were relatively low, and no difference in hip fracture has been demonstrated. A population-based cohort of 2003 breast cancer survivors ≥65 were followed prospectively for a median of 36 months. Patient survey information regarding adjuvant breast cancer therapies, prescription osteoporosis treatments, and other factors potentially associated with fracture was supplemented with cancer registry information. Hip and total nonvertebral fractures were determined using a validated Medicare algorithm, and the association of these fractures with adjuvant hormonal therapies was examined using Cox models. The cohort of 2,748 women with a mean age of 72.8 (SD 5.4) included 28.2% who took an aromatase inhibitor and 27.8% tamoxifen. There were 41 hip fractures (1.5%) and 218 nonvertebral fractures (7.9%) among the cohort. Subjects using AIs (adjusted hazard ratio 3.24 (1.05, 9.98)) and subjects not using hormone therapy (3.32 (1.14, 9.65)) were more likely than users of tamoxifen to have a hip fracture. Bisphosphonate use was more common among AI users but did not explain these results. Users of AIs were more likely to have nonvertebral fractures, but this result did not reach statistical significance (adjusted hazard 1.34 (0.92, 1.94)). Hip and other fractures were common in an older population-based cohort of breast cancer survivors, and aromatase inhibitor use was associated with an increase in the short-term risk of hip fractures not detected in randomized controlled trials" @default.
• W2002292011 created "2016-06-24" @default.
• W2002292011 creator A5045879447 @default.
• W2002292011 creator A5048741049 @default.
• W2002292011 creator A5058220968 @default.
• W2002292011 creator A5073632935 @default.
• W2002292011 creator A5084631368 @default.
• W2002292011 date "2010-12-18" @default.
• W2002292011 modified "2023-10-18" @default.
• W2002292011 title "Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients" @default.
• W2002292011 cites W1453600927 @default.
• W2002292011 cites W1529243395 @default.
• W2002292011 cites W1562190372 @default.
• W2002292011 cites W1936024593 @default.
• W2002292011 cites W1978649184 @default.
• W2002292011 cites W1981476886 @default.
• W2002292011 cites W1987994024 @default.
• W2002292011 cites W2009508470 @default.
• W2002292011 cites W2040573139 @default.
• W2002292011 cites W2041371036 @default.
• W2002292011 cites W2041709717 @default.
• W2002292011 cites W2061839701 @default.
• W2002292011 cites W2064936613 @default.
• W2002292011 cites W2065224313 @default.
• W2002292011 cites W2072985818 @default.
• W2002292011 cites W2074048861 @default.
• W2002292011 cites W2079772953 @default.
• W2002292011 cites W2096446019 @default.
• W2002292011 cites W2097741826 @default.
• W2002292011 cites W2100291515 @default.
• W2002292011 cites W2101881391 @default.
• W2002292011 cites W2108326787 @default.
• W2002292011 cites W2111387898 @default.
• W2002292011 cites W2113142553 @default.
• W2002292011 cites W2121099142 @default.
• W2002292011 cites W2121656289 @default.
• W2002292011 cites W2124903864 @default.
• W2002292011 cites W2126856198 @default.
• W2002292011 cites W2127677509 @default.
• W2002292011 cites W2134350728 @default.
• W2002292011 cites W2141647078 @default.
• W2002292011 cites W2146194560 @default.
• W2002292011 cites W2146235472 @default.
• W2002292011 cites W2153579902 @default.
• W2002292011 cites W2155462687 @default.
• W2002292011 cites W2163688875 @default.
• W2002292011 cites W2163830908 @default.
• W2002292011 cites W2163852287 @default.
• W2002292011 cites W2165680991 @default.
• W2002292011 cites W2166969772 @default.
• W2002292011 cites W2167238270 @default.
• W2002292011 cites W2167469083 @default.
• W2002292011 cites W2168772783 @default.
• W2002292011 cites W2323830513 @default.
• W2002292011 cites W4230523829 @default.
• W2002292011 doi "https://doi.org/10.1007/s00198-010-1493-x" @default.
• W2002292011 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3166362" @default.
• W2002292011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21170643" @default.
• W2002292011 hasPublicationYear "2010" @default.
• W2002292011 type Work @default.
• W2002292011 sameAs 2002292011 @default.
• W2002292011 citedByCount "32" @default.
• W2002292011 countsByYear W20022920112012 @default.
• W2002292011 countsByYear W20022920112013 @default.
• W2002292011 countsByYear W20022920112014 @default.
• W2002292011 countsByYear W20022920112015 @default.
• W2002292011 countsByYear W20022920112016 @default.
• W2002292011 countsByYear W20022920112017 @default.
• W2002292011 countsByYear W20022920112018 @default.
• W2002292011 countsByYear W20022920112019 @default.
• W2002292011 countsByYear W20022920112020 @default.
• W2002292011 countsByYear W20022920112021 @default.
• W2002292011 crossrefType "journal-article" @default.
• W2002292011 hasAuthorship W2002292011A5045879447 @default.
• W2002292011 hasAuthorship W2002292011A5048741049 @default.
• W2002292011 hasAuthorship W2002292011A5058220968 @default.
• W2002292011 hasAuthorship W2002292011A5073632935 @default.
• W2002292011 hasAuthorship W2002292011A5084631368 @default.
• W2002292011 hasBestOaLocation W20022920112 @default.
• W2002292011 hasConcept C121608353 @default.
• W2002292011 hasConcept C126322002 @default.
• W2002292011 hasConcept C143998085 @default.
• W2002292011 hasConcept C1862650 @default.
• W2002292011 hasConcept C201903717 @default.
• W2002292011 hasConcept C207103383 @default.
• W2002292011 hasConcept C2776541429 @default.
• W2002292011 hasConcept C2777176818 @default.
• W2002292011 hasConcept C2778311097 @default.
• W2002292011 hasConcept C2778885795 @default.
• W2002292011 hasConcept C2908647359 @default.
• W2002292011 hasConcept C29456083 @default.
• W2002292011 hasConcept C44249647 @default.
• W2002292011 hasConcept C50382708 @default.
• W2002292011 hasConcept C530470458 @default.
• W2002292011 hasConcept C71924100 @default.
• W2002292011 hasConcept C72563966 @default.
• W2002292011 hasConcept C99454951 @default.
• W2002292011 hasConceptScore W2002292011C121608353 @default.

• next